A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2022 and how those developments will impact future cases. They will discuss important precedent promulgated last year, and we will also hear about Director Vidal’s impact on the PTAB during 2022, including a summary of those cases where Director Review was granted. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2023.

This webinar will provide a roundup of this year’s most significant intellectual property cases. Our panelists are three litigators in private practice, all members of IPO’s Amicus Brief Committee. They will review the most significant decisions as of 2022 and give a sneak peek at coming attractions.

Patent Center, which currently is being rolled out by the USPTO, will soon become the platform for all patent-related submissions. Panelists will discuss what Patent Center is, the platforms being replaced, and the various features of Patent Center. Panelists will discuss the new DOCX patent filing requirements, the related pros and cons, and offer best practice tips associated with DOCX filings.

Our panel of IP operations and technology veterans will provide an overview of the evolving technical and service landscapes and introduce you to new, cutting-edge solutions to simplify your IP back office that are increasing accuracy and efficiency while simultaneously reducing cost, headcount, and risk.

This presentation will focus on just a few ways that analytics are helping patent practitioners become both more efficient and more effective – and do so in the context of practitioners’ ethical responsibility to be knowledgeable about the benefits and risks associated with relevant technology. *This webinar is sponsored by LexisNexis *IPO will apply for CLE Ethics credit for this course

This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. In addition to demystifying the technology, the panel will discuss how AI and machine learning has revolutionized IP enforcement in the online environment—for example through platforms incorporating AI that assist in identifying online sales of counterfeit products. The panel will also provide brand owner, patent practitioner, and legislative perspectives on AI & machine learning.

This program covers the common ethics issues that IP attorneys confront on a regular basis. Topics include: • New rules and key opinions • Confidentiality and privilege in IP cases, including issues arising from protective order violations • Duty of loyalty and conflict issues • Duties related to candor to the USPTO and courts • Duties regarding third parties • USPTO OED rule changes and disciplinary decisions

This webinar will focus on the history and context of the agencies’ 2013, 2019, and (draft) 2021 policy statements, as well as the legal impact of their withdrawal. It will also include a discussion of where the U.S. government, standards organizations, and private parties should go from here.

In this webinar, the panel will discuss the basics around what the myth of the meritocracy is and how it affects the legal profession. The panel will be using the published white paper as our guide.

This webinar will focus on the Unified Patent Court and how it will change the way businesses operate in this new world. Join our expert panel—Bettina Wanner of Bayer Intellectual Property GmbH, Boris Kreye of Bird & Bird LLP, and Jakob Kellenberger of Procter & Gamble Services Co. NV—to learn more about the UPC.

The webinar will discuss real stories about challenges in leadership and advancement and consider hypotheticals on how panelists would respond to specific challenging fact patterns. This will include discussion about how changes in leadership styles can make a positive impact on those who continue to be negatively impacted in a post-2020 world, including discussing mental burdens, lack of barrier between work and home, the downsides of “flexibility,” other inequities, and leading across generations.

There is no question that the legal field remains one of the least diverse professions in the United States. Not only are men overrepresented in the practice of law, but they outnumber women in equity partner positions nearly five to one. The statistics become even grimmer when we examine patent attorneys, who need both a law degree and a hard science degree. In the wake of a new study indicating that the Mansfield Rule is not as effective as thought for increasing diversity, what is our industry to do? Join our distinguished panelists who have taken action to help diversity the patent bar. Learn about their innovative and collaborative programs and how you can get involved to be part of the solution.

Join IPO to hear from the USPTO and WIPO on the implementation of the World Intellectual Property Office (WIPO) Standard ST.26 as the experts discuss the changes to sequence listings filed in patent applications that contain disclosures of nucleotide and/or amino acid sequences. WIPO Standard ST.26, requiring XML formatting, went into effect worldwide on July 1, 2022. The USPTO has adopted new rules to implement this Standard as published at 87 Fed Reg. 30806, (May 20, 2022). The presentation will provide guidance on how you will be able to prepare and submit a compliant sequence listing in U.S. patent applications and PCT applications filed on or after July 1, 2022.